United Therapeutics (NASDAQ:UTHR) Price Target Raised to $348.00
United Therapeutics (NASDAQ:UTHR – Free Report) had its price target lifted by Morgan Stanley from $346.00 to $348.00 in a research note released on Thursday,Benzinga reports. They currently have an equal weight rating on the biotechnology company’s stock. A number of other brokerages also recently issued reports on UTHR. Bank of America upgraded United Therapeutics […]
United Therapeutics (NASDAQ:UTHR – Free Report) had its price target lifted by Morgan Stanley from $346.00 to $348.00 in a research note released on Thursday,Benzinga reports. They currently have an equal weight rating on the biotechnology company’s stock. A number of other brokerages also recently issued reports on UTHR. Bank of America upgraded United Therapeutics […]
